Pyrimidin-2-amine derivates and their use as A2B adenosine receptor antagonists

Details for Australian Patent Application No. 2004283800 (hide)

International Classifications

Event Publications

13 April 2006 PCT application entered the National Phase

PCT publication WO2005/040155 Priority application(s): WO2005/040155

10 July 2008 Alteration of Name

The name of the applicant has been altered to Laboratorios Almiral, S.A.

7 May 2009 Application Accepted

Published as AU-B-2004283800

18 June 2009 Corrigenda

Applications Accepted - Name Index Under the name Laboratorios Almiral, S.A., Application No. 2004283800, under INID(71) correct the applicant name to Laboratorios Almirall, S.A.

3 September 2009 Standard Patent Sealed

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.